Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsSaberi Hosnijeh, Fatemeh
Krop, Esmeralda J.M.
MetadataShow full item record
AbstractRecently, biological markers related to the immune system such as cytokines have been studied to further understand the etiology of non-Hodgkin Lymphoma (NHL). However, to date, there are no studies that have studied cytokine levels prospectively in relation to NHL risk in the general population.
Using bead-based immunoassays, plasma levels of 11 cytokines, 4 chemokines, and 1 adhesion molecules were measured in prediagnostic blood samples of 86 NHL cases and 86 matched controls (average time between blood collection and diagnosis, 4.5 y). Conditional logistic regression adjusted for body mass index and alcohol consumption was used to analyze the association between individual plasma cytokine levels and the risk of developing NHL.
In multivariate models, excluding cases diagnosed within 2 years after inclusion, we observed a significant association for interleukin 2 (IL2; P trend = 0.004), interferon (IFN)-gamma (P trend = 0.05), and intercellular adhesion molecule (ICAM) (P trend = 0.04). Subanalyses of B-cell NHL patients showed a significant association with IL2 (P trend = 0.003), tumor necrosis factor-alpha (TNF-alpha; P trend = 0.03), and ICAM (P trend = 0.04) and a borderline association with IL5 (P trend = 0.07) and IFN-gamma (P trend = 0.08).
The results of this study suggest, in a prospective setting, a possible association between plasma levels of IL2, ICAM, IFN-gamma, and TNF-alpha with NHL risk and provide some evidence that risk of NHL might be related to a downregulation of T helper 1 cytokines.
Identification of subtle changes in immune response regulation quantified by plasma cytokine levels possibly provides new insights in the etiology of NHL.
CitationCancer Epidemiol. Biomarkers Prev. 2010, 19 (6):1577-1584
SponsorsThe EPIC study was funded by “Europe Against Cancer” Programme of the European Commission (SANCO), Italian Association for Research on Cancer, Italian National Research Council, and Compagnia di San Paolo. This work was supported by the Environmental Cancer Risk, Nutrition and Individual Susceptibility Network of Excellence, operating within the European Union 6th Framework Program, Priority 5: Food Quality and Safety (FOOD-CT-2005-513943). F. Saberi Hosnijeh acknowledges the Iranian Ministry of Health and Medical Education for support of a Ph.D. program at Utrecht University.
- Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
- Authors: Cerhan JR, Bernstein L, Severson RK, Davis S, Colt JS, Blair A, Hartge P
- Issue date: 2005 Dec
- Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.
- Authors: Edlefsen KL, Martínez-Maza O, Madeleine MM, Magpantay L, Mirick DK, Kopecky KJ, LaCroix AZ, De Roos AJ
- Issue date: 2014 Aug 15
- Residential history, family characteristics and non-Hodgkin lymphoma, a population-based case-control study in the San Francisco Bay Area.
- Authors: Bracci PM, Dalvi TB, Holly EA
- Issue date: 2006 Jul
- Atopy and risk of non-Hodgkin lymphoma.
- Authors: Melbye M, Smedby KE, Lehtinen T, Rostgaard K, Glimelius B, Munksgaard L, Schöllkopf C, Sundström C, Chang ET, Koskela P, Adami HO, Hjalgrim H
- Issue date: 2007 Jan 17
- Birth order, atopy, and risk of non-Hodgkin lymphoma.
- Authors: Grulich AE, Vajdic CM, Kaldor JM, Hughes AM, Kricker A, Fritschi L, Turner JJ, Milliken S, Benke G, Armstrong BK
- Issue date: 2005 Apr 20